Allitinib Tosylate | m-entrepreneurship.com

Product Name :
Allitinib Tosylate

Search keywords :
Allitinib

drugId :
null

Target Vo:
Epidermal growth factor receptor erbB1

Target Vo Short Name :
EGFR

Moa_Name:
Epidermal growth factor receptor erbB1 antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Shanghai Allist Pharmaceutical Technology Co Ltd

Active Company_Name :
Shanghai Allist Pharmaceutical Technology Co Ltd

Active Indication_Name:
Carcinoma, Non-Small-Cell Lung

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:
Phase 2 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-ULK1 (Ser556) Antibody
PFKFB3 Antibody
RSK1 p90 Antibody (YA088): RSK1 p90 Antibody (YA088) is a non-conjugated and Rabbit origined monoclonal antibody about 83 kDa, targeting to RSK1 p90. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts